BDTX (Black Diamond Therapeutics) Tariff Resilience Score: 5/10 (As of Jul. 04, 2026)


BDTX Black Diamond Therapeutics Inc BDTX
37 GF Score
Price $2.02
! 2 Warning Signs
View Full Analysis

What is Black Diamond Therapeutics Tariff Resilience Score?

Black Diamond Therapeutics BDTX +9.24% 37 Tariff Resilience Score is 5 as of Jul. 04, 2026. GuruFocus rates BDTX with a GF Score™ of 37/100. The stock has 2 warning signs investors should review. Among 1,373 Biotechnology companies, Black Diamond Therapeutics ranks better than 62.27% on this metric.

Black Diamond Therapeutics has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Black Diamond Therapeutics has As a biotech firm, it faces moderate tariff risks due to global supply chain dependencies. However, its innovative product pipeline and potential for alternative suppliers offer some mitigation.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Black Diamond Therapeutics might have Average Resilient.

Black Diamond Therapeutics  (NAS:BDTX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Black Diamond Therapeutics Tariff Resilience Score Related Terms

BDTX vs CGTX, PMN, PTHS: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Black Diamond Therapeutics's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Black Diamond Therapeutics Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Black Diamond Therapeutics's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Black Diamond Therapeutics's Tariff Resilience Score falls into.


BDTX
37GF Score
Black Diamond Therapeutics Inc BDTX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Black Diamond Therapeutics (BDTX) has a Tariff Resilience Score of 5 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Black Diamond Therapeutics ranks #518 out of 1373 companies in the Biotechnology industry, placing it in the top 37.7%.
Is Black Diamond Therapeutics' Tariff Resilience Score too high?
Black Diamond Therapeutics' current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Black Diamond Therapeutics' value of 5 is 25% above this industry median. Based on the distribution chart, Black Diamond Therapeutics ranks #518 out of 1373 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Black Diamond Therapeutics has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Black Diamond Therapeutics' Tariff Resilience Score compare to CGTX and PMN?
According to the Biotechnology industry distribution chart, Black Diamond Therapeutics ranks #518 out of 1373 companies for Tariff Resilience Score. This puts Black Diamond Therapeutics in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Black Diamond Therapeutics' value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,373 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Black Diamond Therapeutics's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Black Diamond Therapeutics's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Black Diamond Therapeutics stock overvalued right now?
Black Diamond Therapeutics (BDTX) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Black Diamond Therapeutics' overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Black Diamond Therapeutics (BDTX), the current Tariff Resilience Score is 5 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Black Diamond Therapeutics Business Description

Address 245 First Street, 18th Floor, Cambridge, MA, USA, 02142
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.
37GF Score

Get the complete analysis for BDTX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.02
Price